PROFILBARU.COM

Kebuzone
Clinical data
Routes of; administration	intramuscular
ATC code	M01AA06 (WHO) ;
Pharmacokinetic data
Elimination half-life	70–100 hours
Excretion	renal
Identifiers
	IUPAC name 4-(3-oxobutyl)-1,2-di(phenyl)pyrazolidine-3,5-dione;
CAS Number	853-34-9 ;
PubChem CID	3824;
DrugBank	DB08940 ;
ChemSpider	3692 ;
UNII	4VD83UL6Y6;
KEGG	D01567 ;
ChEBI	CHEBI:31749 ;
CompTox Dashboard (EPA)	DTXSID00234500 ;
ECHA InfoCard	100.011.560
Chemical and physical data
Formula	C19H18N2O3
Molar mass	322.364 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES CC(=O)CCC1C(=O)N(N(C1=O)C2=CC=CC=C2)C3=CC=CC=C3;
	InChI InChI=1S/C19H18N2O3/c1-14(22)12-13-17-18(23)20(15-8-4-2-5-9-15)21(19(17)24)16-10-6-3-7-11-16/h2-11,17H,12-13H2,1H3 ; Key:LGYTZKPVOAIUKX-UHFFFAOYSA-N ;
	(what is this?) (verify)

Kebuzone (or ketophenylbutazone) is a nonsteroidal anti-inflammatory drug (NSAID) that is used for the treatment of inflammatory conditions such as thrombophlebitis and rheumatoid arthritis (RA).^[1]^[2]^[3]

References

^ Austria-Codex (in German). Vienna: Österreichischer Apothekerverlag. 2018. Rheumesser 3 ml-Ampullen.
^ "KEBUZONE". NCATS Inxight: Drugs. Retrieved 2019-02-27.
^ Aronson JK (2016). "Kebuzone". Meyler's Side Effects of Drugs: The International Encyclopedia of Adverse Drug Reactions and Interactions (Sixteenth ed.). Amsterdam. p. 405. ISBN 978-0-444-53716-4.{{cite book}}: CS1 maint: location missing publisher (link)